222 related articles for article (PubMed ID: 18785621)
21. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
[TBL] [Abstract][Full Text] [Related]
22. Malignancies in primary biliary cirrhosis.
Piscaglia F; Sagrini E
Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):1-4. PubMed ID: 18090981
[TBL] [Abstract][Full Text] [Related]
23. Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC).
Floreani A; Biagini MR; Chiaramonte M; Milani S; Surrenti C; Naccarato R
Ital J Gastroenterol; 1993; 25(9):473-6. PubMed ID: 8123893
[TBL] [Abstract][Full Text] [Related]
24. [Screening for hepatocarcinoma in a cohort with cirrhosis mainly of alcoholic origin].
Henrion J; Libon E; De Maeght S; Deltenre P; Schapira M; Ghilain JM; Maisin JM; Heller FR
Gastroenterol Clin Biol; 2003 May; 27(5):534-9. PubMed ID: 12843918
[TBL] [Abstract][Full Text] [Related]
25. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
El-Serag HB; Davila JA
Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
[TBL] [Abstract][Full Text] [Related]
26. Clinical prognostic variables in young patients (under 40 years) with hepatitis B virus-associated hepatocellular carcinoma.
Wang Q; Luan W; Villanueva GA; Rahbari NN; Yee HT; Manizate F; Hiotis SP
J Dig Dis; 2012 Apr; 13(4):214-8. PubMed ID: 22435506
[TBL] [Abstract][Full Text] [Related]
27. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
[TBL] [Abstract][Full Text] [Related]
28. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
[TBL] [Abstract][Full Text] [Related]
29. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
[TBL] [Abstract][Full Text] [Related]
30. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M
Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142
[TBL] [Abstract][Full Text] [Related]
31. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.
Amarapurkar D; Han KH; Chan HL; Ueno Y;
J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082
[TBL] [Abstract][Full Text] [Related]
32. Prediction of hepatocellular carcinoma development by aminotransferase to platelet ratio index in primary biliary cholangitis.
Cheung KS; Seto WK; Fung J; Mak LY; Lai CL; Yuen MF
World J Gastroenterol; 2017 Nov; 23(44):7863-7874. PubMed ID: 29209127
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinoma in primary biliary cirrhosis: a case report and review of the Japanese literature.
Shimizu A; Koyama M; Okuda Y; Takase K; Nakano T; Tameda Y
Hepatogastroenterology; 1998; 45(24):2352-5. PubMed ID: 9951922
[TBL] [Abstract][Full Text] [Related]
34. Hepatocellular cancer: optimal strategies for screening and surveillance.
Cabibbo G; Craxì A
Dig Dis; 2009; 27(2):142-7. PubMed ID: 19546552
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology, risk factors and surveillance of hepatocellular carcinoma.
Cabibbo G; Craxì A
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):352-5. PubMed ID: 20496547
[TBL] [Abstract][Full Text] [Related]
36. Clinical features in hepatocellular carcinoma and the impact of autopsy on diagnosis. A study of 530 cases from a low-endemicity area.
Kaczynski J; Hansson G; Wallerstedt S
Hepatogastroenterology; 2005; 52(66):1798-802. PubMed ID: 16334780
[TBL] [Abstract][Full Text] [Related]
37. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.
Cucchetti A; Piscaglia F; Caturelli E; Benvegnù L; Vivarelli M; Ercolani G; Cescon M; Ravaioli M; Grazi GL; Bolondi L; Pinna AD
Ann Surg Oncol; 2009 Feb; 16(2):413-22. PubMed ID: 19034578
[TBL] [Abstract][Full Text] [Related]
38. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey.
Chalasani N; Said A; Ness R; Hoen H; Lumeng L
Am J Gastroenterol; 1999 Aug; 94(8):2224-9. PubMed ID: 10445554
[TBL] [Abstract][Full Text] [Related]
39. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B.
Yuen MF; Tanaka Y; Fong DY; Fung J; Wong DK; Yuen JC; But DY; Chan AO; Wong BC; Mizokami M; Lai CL
J Hepatol; 2009 Jan; 50(1):80-8. PubMed ID: 18977053
[TBL] [Abstract][Full Text] [Related]
40. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
